quinone methide has been researched along with phosphatidylcholines in 1 studies
| Studies (quinone methide) | Trials (quinone methide) | Recent Studies (post-2010) (quinone methide) | Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) |
|---|---|---|---|---|---|
| 374 | 0 | 232 | 32,204 | 443 | 5,593 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Estévez-Braun, A; Lacal, JC; Pérez-Sacau, E; Ravelo, AG | 1 |
1 other study(ies) available for quinone methide and phosphatidylcholines
| Article | Year |
|---|---|
A new family of choline kinase inhibitors with antiproliferative and antitumor activity derived from natural products.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Arthritis, Rheumatoid; Biological Products; Cell Line, Tumor; Cell Proliferation; Choline Kinase; HT29 Cells; Humans; Indolequinones; Inhibitory Concentration 50; Maximum Tolerated Dose; Mice; Mice, Nude; Molecular Docking Simulation; Neoplasm Transplantation; Neoplasms; Phosphatidylcholines; Recombinant Proteins; Triterpenes | 2015 |